The National Lipedema Study

Launched by HARALDSPLASS DEACONESS HOSPITAL · Mar 8, 2022

Keywords

ClinConnect Summary

The National Lipedema Study is a clinical trial designed to investigate the effects of different treatments for lipedema, a condition that mainly affects women and involves painful swelling due to an abnormal buildup of fatty tissue in the legs and arms. This study aims to gather more information about how effective treatments, such as liposuction, can be in managing this condition, especially since there is currently not enough scientific evidence to support surgical options.

To participate in the trial, women aged 20 to 65 who experience significant pain from lipedema may be eligible, provided they are in the early stages of the condition. Participants can expect to follow a specific treatment plan over five years, with regular check-ins to monitor progress. The study hopes to provide valuable insights into the best ways to treat lipedema, which could improve future care for patients and help healthcare providers make informed decisions. If you have any questions about your eligibility or the study, healthcare providers can provide more information.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • female
• • age 20-65 years
• • significant pain from lipedema
• • lipedema stage 1-2 or localized stage 3
• Exclusion Criteria:
• • Non-fluency in the Norwegian language
• • pregnancy
• • current malignancy
• • previous surgical treatment for lipedema
• • smoking
• • BMI \> 28
• • serious comorbidities such as cardiac-, pulmonary-, renal disease
• • unwillingness to wear compression garments

Trial Officials